Flurbiprofen CAS 5104-49-4 Assay 99.0~100.5% (HPLC) Factory
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili weFlurbiprofen (CAS: 5104-49-4) enomgangatho ophezulu.I-Ruifu Chemical inokubonelela ngenkonzo yehlabathi jikelele, ixabiso elikhuphisanayo, inkonzo egqwesileyo, encinci kunye nezixa ezininzi ezikhoyo.Thenga iFlurbiprofen (CAS: 5104-49-4),Please contact: alvin@ruifuchem.com
Igama leMchiza | I-Flurbiprofen |
Izithethantonye | I-2-(2-Fluorobiphenyl-4-yl) ipropionic Acid;Ansaid;Flurizan;(±)-Flurbiprofen;DL-Flurbiprofen;(±)-2-Fluoro-α-Methyl-4-Biphenylacetic Acid;L-790,330;I-2-Fluoro-α-Methyl-[1,1'-Biphenyl]-4-Acetic Acid |
Ubume beStokhwe | Kwi-Stock, iMveliso yoRhwebo |
Inombolo yeCAS | 5104-49-4 |
Ifomula yeemolekyuli | I-C15H13FO2 |
Ubunzima beMolekyuli | 244.27 g/mol |
Indawo yokunyibilika | 114.0 ~ 117.0℃ |
Ukuxinana | 1.199±0.06 g/cm3 |
Ukunyibilika kwamanzi | Inyibilika kancinane emanzini |
Ukunyibilika | Inyibilika kwiMethanol, Phantse Ukungafihli |
I-COA kunye ne-MSDS | Iyafumaneka |
Isampulu | Iyafumaneka |
Imvelaphi | Shanghai, China |
Uphawu | Ruifu Chemical |
Izinto | Iinkcukacha | Iziphumo |
Imbonakalo | Umgubo weCrystalline oMhlophe okanye ophantse wamhlophe | Iyahambelana |
Ukuchongwa (IR) | Ihambelana ne-Reference Spectrum | Iyahambelana |
Ukuchongwa (nge UV) | Ixesha lokuGcinwa kweNcopho ePhambili ehambelana noMgaqo woNxibelelwano | Iyahambelana |
Imbonakalo yesisombululo | Icacile kwaye ayinaMbala | Iyahambelana |
Indawo yokunyibilika | 114.0 ~ 117.0℃ | 115.0 ~ 117.0℃ |
Ujikelezo oluKhethekileyo [a]20/D | -0.1 ° ukuya +0.1 ° | -0.0017 ° |
Ilahleko ekomisweni | ≤0.50% | 0.15% |
Intsalela kwi-Ignition | ≤0.10% | 0.05% |
Iintsimbi ezinzima | ≤10ppm | <10ppm |
Izinto ezinxulumeneyo | ||
Ukungcola A | ≤0.20% | 0.01% |
Ukungcola B | ≤0.20% | ND |
Ukungcola C | ≤0.20% | ND |
Ukungcola D | ≤0.20% | ND |
Ukungcola E | ≤0.20% | ND |
Nakuphi na Okunye Ukungacoceki komntu | ≤0.10% | 0.04% |
Isimbuku sobumdaka ngaphandle kuka-A | ≤1.00% | 0.16% |
Izinyibilikisi ezishiyekileyo | ||
Inyibilikisi A | ≤0.041% | 0.01% |
Isinyibilikisi B | ≤0.0002% | ND |
I-Solvent C | ≤0.089% | ND |
Indlela yoVavanyo / yoHlahlelo | 99.0% ~ 100.5% (HPLC, kwiDried Basis) | 99.2% |
Ukuqukumbela | Imveliso ivavanyiwe kwaye ihambelana neenkcukacha ezinikiweyo |
Umqulu:Ibhotile eFluorinated, iAluminium foil bag, 25kg/Cardboard Drum, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina isikhongozeli sivalwe ngokuqinileyo kwaye usigcine kwindawo epholileyo, eyomileyo (2~8℃) kunye nendawo yokugcina impahla engena moya ikude kwizinto ezingahambelaniyo.Khusela ukukhanya kunye nokufuma.
Ukuhambisa ngenqanawe:Zisa kwihlabathi liphela ngomoya, ngeFedEx / DHL Express.Ukubonelela ngokukhawuleza nangokuthembekileyo.
I-Flurbiprofen
C15H13FO2 244.27
(±) -2- (2-Fluoro-4-biphenylyl) ipropionic acid [5104-49-4].
I-Flurbiprofen iqulethe ngaphantsi kweepesenti ze-99.0 kwaye ingabi ngaphezu kwe-100.5 ipesenti ye-C15H13FO2, ibalwa kwisiseko esomileyo.
Ukupakishwa kunye nokugcinwa- Gcina kwizikhongozeli eziqinileyo.
Imigangatho yezalathiso ye-USP <11>-
USP Flurbiprofen RS
USP Flurbiprofen Related Compound A RS
2-(4-Biphenylyl) propionic acid.
C15H14O2 226.28
Isazisi-
A: I-Infrared Absorption <197K>.
B:Ukufunxwa kweUltraviolet 197U-
Isisombululo: 10 µg ngemL.
Phakathi: 0.1 N sodium hydroxide.
Ubuninzi be-Absorbance kwi-247 nm malunga ne-0.8.
Uluhlu olunyibilikayo <741>: phakathi kwe-114 kunye ne-117.
Ilahleko ekumiseni <731>-Yomise kwi-vacuum kwi-60 ukuya kubunzima obuqhubekayo: ilahlekelwa ngaphezu kwe-0.5% yobunzima bayo.
Intsalela ekutshisweni <281>: hayi ngaphezulu kwe-0.1%.
Iintsimbi ezinzima, Indlela II <231>: 0.001%.
Iikhompawundi ezinxulumene-
I-Diluent-Lungisa umxube wamanzi kunye ne-acetonitrile (11: 9).
Isigaba esiphathwayo-Lungisa umxube ohluziweyo kunye ne-degassed yamanzi, i-acetonitrile, kunye ne-glacial acetic acid (12: 7: 1).Yenza uhlengahlengiso xa kukho imfuneko (jonga ukufaneleka kweNkqubo phantsi kweChromatography <621>).
Isisombululo sesitokhwe esisemgangathweni- Nyibilikisa isixa esinomlinganiso ochanekileyo weUSP Flurbiprofen Related Compound A RS in Diluent ukufumana isisombululo esinoxinzelelo olumalunga nama 50 µg ngemL.
Isisombululo sokufaneleka kwenkqubo-I-Pipet 2.0 mL yesisombululo se-Standard stock kwi-flask ye-volumetric ye-10-mL, yongeza malunga ne-20 mg ye-USP Flurbiprofen RS, ihlambulule nge-Diluent ukuya kwivolumu, kwaye udibanise.
Isisombululo esisemgangathweni-Ukudlulisa i-2.0 mL yesisombululo sesitokhwe esisemgangathweni kwi-flask ye-volumetric ye-10.0-mL, xuba nge-Diluent kwivolumu, kwaye udibanise.
Isisombululo sovavanyo-Lungisa isisombululo se-Flurbiprofen kwi-Diluent equlethe i-2.0 mg nge-mL.
Inkqubo yeChromatographic (jonga i-Chromatography <621>)-I-chromatograph yolwelo ixhotyiswe nge-254-nm detector kunye nekholamu ye-3.9-mm × 15-cm equlethe i-4-µm yokupakisha i-L1.Izinga lokuhamba malunga ne-1 mL ngomzuzu.I-Chromatograph isisombululo sokufaneleka kweSistim, kwaye urekhode iimpendulo eziphezulu njengoko ziqondiswe kwiNkqubo: amaxesha okugcinwa okuhambelanayo malunga ne-0.9 ye-Flurbiprofen ehambelana ne-compound A kunye ne-1.0 ye-flurbiprofen;kunye nokutenxa komgangatho ozalanayo wokuphindaphinda iinaliti akukho ngaphezu kwe-1.0%.
Inkqubo-Ngokwahlukileyo tofa imithamo elinganayo (malunga nama-20 µL) yesisombululo soMgangatho kunye nesisombululo soVavanyo kwichromatograph, urekhode iichromatogram, kwaye ulinganise iindawo zeencopho ezinkulu.Bala ipesenti ye-flurbiprofen enxulumene nekhompawundi A kwinxalenye yeFlurbiprofen ethathwe yifomula:
100(CS / CU)(rU / rS)
apho i-CS lugxininiso, kwi-µg ngemL, ye-USP Flurbiprofen eNxulumene neCompound A RS kwisisombululo esiseMgangathweni;I-CU luxinzelelo, kwi-µg ngemL nganye, yeFlurbiprofen kwisisombululo soVavanyo;kunye ne-rU kunye ne-rS ziyincopho yeempendulo ze-flurbiprofen ehambelana nekhompawundi A efunyenwe kwisisombululo soVavanyo kunye nesisombululo soMgangatho, ngokulandelelana: akukho ngaphezu kwe-0.5% ye-flurbiprofen enxulumene nekhompawundi A ifunyenwe.Bala ipesenti yokungahlambuluki ngakunye kwinxalenye yeFlurbiprofen ethathwe ngefomula:
100(ri / rs)
apho ri yincopho impendulo yokungcola nganye efunyenwe kwisisombululo Test;kunye ne-rs sisimbuku seempendulo zazo zonke iincopho ezifunyenwe kwisisombululo soVavanyo: isixa sabo bonke ukungcola akukho ngaphezu kwe-1.0%.
I-Assay-Dissolve malunga ne-0.5 g ye-Flurbiprofen, ilinganiswe ngokuchanekileyo, kwi-100 mL yotywala, ngaphambili ingathathi hlangothi nge-0.1 N sodium hydroxide VS kwi-phenolphthalein endpoint, yongeza i-phenolphthalein TS, kunye ne-titrate nge-0.1 Nsodium hydroxide VS kwimbonakalo yokuqala ye-faint ye-faint yokuqala. umbala opinki ozingisayo ungekho ngaphantsi kwemizuzwana engama-30.I-mL nganye ye-0.1 N i-sodium hydroxide ilingana ne-24.43 mg ye-C15H13FO2.
Ukuthenga njani?Nceda uqhagamshelaneDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Amava Eminyaka Eli-15?Sineminyaka engaphezu kwe-15 yamava ekwenziweni nasekuthumeleni kumazwe angaphandle uluhlu olubanzi oluphezulu lwamayeza aphakathi okanye amachiza alungileyo.
Iimarike eziphambili?Thengisa kwimarike yasekhaya, eMntla Melika, eYurophu, eIndiya, eKorea, eJapan, eOstreliya, njl.
Iingenelo?Umgangatho ophezulu, ixabiso elifikelelekayo, iinkonzo zengcali kunye nenkxaso yobugcisa, ukuhanjiswa ngokukhawuleza.
UmgangathoIsiqinisekiso?Inkqubo yokulawula umgangatho ongqongqo.Izixhobo zobuchwephesha zokuhlalutya ziquka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njl.
Iisampulu?Uninzi lweemveliso zibonelela ngeesampulu zasimahla zokuvavanya umgangatho, iindleko zokuthumela kufuneka zihlawulwe ngabathengi.
Factory Audit?Uphicotho-zincwadi lwasefektri wamkelekile.Nceda wenze idinga kwangaphambili.
MOQ?Akukho MOQ.Umyalelo omncinci wamkelekile.
Ixesha lokuzisa? Ukuba ngaphakathi kwesitokhwe, ukuhanjiswa kweentsuku ezintathu kuqinisekisiwe.
Ezothutho?Nge-Express (FedEx, DHL), ngoMoya, ngoLwandle.
Amaxwebhu?Emva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njl.
Udibaniso lweSiko?Inokubonelela ngeenkonzo zesiko lokudibanisa ukuze zilungele iimfuno zakho zophando.
Immimiselo yokuhlawula?I-invoyisi yeProforma iya kuthunyelwa kuqala emva kokuqinisekiswa kwe-odolo, efakwe kwiinkcukacha zethu zebhanki.Intlawulo nge-T / T (i-Telex Transfer), i-PayPal, i-Western Union, njl.
Iimpawu zeHazard T - zinetyhefu
Iikhowudi zoMngcipheko 25 - zinetyhefu xa ziginyiwe
Inkcazelo yoKhuseleko
S26 - Xa udibana namehlo, hlambulula ngokukhawuleza ngamanzi amaninzi kwaye ufune iingcebiso zonyango.
S36/37/39 - Nxiba iimpahla ezifanelekileyo zokukhusela, iiglavu kunye nokukhusela amehlo / ubuso.
S45 - Kwimeko yengozi okanye ukuba uziva ungaphilanga, funa ingcebiso kagqirha ngokukhawuleza (bonisa ileyibhile nanini na kunokwenzeka.)
Ii-ID ze-UN UN 2811 6.1/PG 2
WGK eJamani 3
Ikhowudi yeHS 2916399090
I-Flurbiprofen (i-CAS: i-5104-49-4) inamandla, i-agent e-nonsteroidal anti-inflammatory esebenzayo ngomlomo (NSAIA / NSAID).I-Flurbiprofen yi-Phenylalanine enamandla yokuchasa ukudumba kunye ne-antipyretic analgesics, inokuthintela i-prostaglandin synthesizing cyclooxygenase ukuba ibe ne-analgesic, anti-inflammatory and antipyretic effects.Imiphumo yayo yokuchasa kunye ne-analgesic ngamaxesha angama-250 kunye namaxesha angama-50 e-aspirin (eyaziwa ngokuba yi-acetylsalicylic acid).Ukufunxa ngomlomo ngokukhawuleza, i-peak plasma concentration iphumelele emva kweeyure ze-1.5, i-half-life yi-3.5 iiyure, inokusabalalisa izicubu ezibanzi, i-PPB yi-99.4%, inokukhuphisana neziyobisi ezinezinga eliphezulu lokubopha iprotheni ye-plasma ukubopha iprotheni ye-plasma .it I-Metabolizes esibindini kwaye ibe yi-flurbiprofen hydroxy kunye ne-aldehyde acid conjugates.I-T1/2 yi-3.5 h.Ukukhutshelwa komchamo nelindle, malunga ne-60% kunye ne-40% ngokulandelelanayo.Ubudala alunampembelelo kwimetabolism yeziyobisi.Isetyenziswa ikakhulu kwi-rheumatoid arthritis, isifo samathambo, i-ankylosing spondylitis, i-osteoarthritis.Ikwasetyenziselwa ukuthintela i-aphasic cystoid patchy edema Emva kokususwa kotyando lwe-lens, inhibiting i-pupillary constrictionsurgery, unyango lokuvuvukala emva kotyando lwe-cataract kunye ne-trabeculoplasty argon laser eye eye.Ikwasebenza kwiintlungu ezibangelwa zezinye izizathu ezinjengokwenzakala, ukukruneka, utyando.
Iziyobisi ezingekho steroidal anti-inflammatory (NSAIDs) zine-anti-inflammatory, analgesic and antipyretic effects, uluhlu lwetyhefu ukusuka kwincinci ukuya enkulu yinaphtone, salenoxyl, sulindac, diclofenac, ibuprofen, ketoprofen, aspirin, naproxen, tolmetin, flurbiprofen, yantongxikang , phenoxyibuprofen, indomethacin, chloromethanoic acid.I-Aspirin inokuba lukhetho lokuqala lwamachiza e-NSAID esintu.Ukuba abantwana abanakukwazi ukunyamezela ukuchasana kwabo ngexesha lonyango, ezinye izidakamizwa ezingekho-steroidal ezichasayo zingasetyenziswa.Ii-COX-2 inhibitors ezikhethiweyo ziye zaphuhliswa eziya kuthi zonke zithathe indawo ye-NSAID zendabuko.Uluhlu olukhethiweyo lwe-COX-2 inhibitors lubandakanya i-Nimesulide (i-Nimesulide), i-rofecoxib (vioxab), i-celecoxib (i-celecoxib), i-etodolac (i-Rodine), i-meloxicam, njl njl. ibonise ukuba i-COX-2 inhibitors ekhethiweyo yayinemiphumo embalwa yesisu kunye ne-renal kwaye ayinayo impembelelo ebalulekileyo ekusebenzeni kweplatelet, inokusetyenziswa njengokhetho lokuqala lonyango oludityanisiweyo lokuqala kubantwana abane-JRA endaweni ye-aspirin.